Suppr超能文献

单发微小乳头状甲状腺癌肿瘤大小对中央区淋巴结转移的影响:一项 1092 例患者的回顾性研究。

Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients.

机构信息

Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Number 1277, Jiefang Road, Wuhan, Hubei Province, China.

出版信息

World J Surg Oncol. 2017 Jul 17;15(1):133. doi: 10.1186/s12957-017-1202-8.

Abstract

BACKGROUND

The morbidity of papillary thyroid microcarcinomas is increasing worldwide. Surgery is the main treatment for papillary thyroid microcarcinomas, and the choice of surgical method partly depends on the T stage of the tumor. However, according to the American Joint Commission on Cancer staging system (7th edition), the T stage of papillary thyroid microcarcinomas with different tumor extent is unclear. We aimed to study the effect of tumor extent and other factors on central lymph node metastasis to explore the relationship between tumor extent and T stage and to identify the risk factors predicting central lymph node metastasis in papillary thyroid microcarcinomas.

METHODS

We included 1092 patients diagnosed with solitary papillary thyroid microcarcinomas between July 2011 and April 2016. The tumor extent and other central lymph node metastasis risk factors were retrospectively analyzed.

RESULTS

Univariate analysis revealed that capsule invasion and extracapsular extension (P = 0.013, <0.001; respectively) were significantly correlated with central lymph node metastasis. On multivariate analysis, extracapsular extension was independent central lymph node metastasis predictors (odds ratio 3.092, 95% CI 1.744-5.484), while capsule invasion was not (odds ratio 1.212, 95% CI 0.890-1.651). In addition, multivariate analysis revealed that male sex, tumor size >5 mm, and age <45 years were independent central lymph node metastasis predictors (odds ratio 2.072, 2.356, 2.302; 95% CI 1.483-2.894, 1.792-3.099, 1.748-3.031; respectively).

CONCLUSIONS

This study supported that capsule invasion and tumor limited to the thyroid in papillary thyroid microcarcinomas were suitable for the lower T1, that is, capsule invasion in papillary thyroid microcarcinomas might not belong to the minimal extrathyroid extension included in T3 of TNM staging. In addition, patients with risk factors of extrathyroid extension, male sex, age <45 years, or tumor size >5 mm in papillary thyroid microcarcinomas should consider a more aggressive surgical treatment.

摘要

背景

全球范围内,甲状腺微小乳头状癌的发病率正在增加。手术是甲状腺微小乳头状癌的主要治疗方法,手术方式的选择部分取决于肿瘤的 T 分期。然而,根据美国癌症联合委员会分期系统(第 7 版),肿瘤范围不同的甲状腺微小乳头状癌的 T 分期并不明确。我们旨在研究肿瘤范围和其他因素对中央区淋巴结转移的影响,以探讨肿瘤范围与 T 分期的关系,并确定甲状腺微小乳头状癌中央区淋巴结转移的预测因素。

方法

我们纳入了 2011 年 7 月至 2016 年 4 月期间诊断为单发甲状腺微小乳头状癌的 1092 例患者。回顾性分析了肿瘤范围和其他中央区淋巴结转移的危险因素。

结果

单因素分析显示,包膜侵犯和包膜外侵犯(P=0.013,<0.001)与中央区淋巴结转移显著相关。多因素分析显示,包膜外侵犯是中央区淋巴结转移的独立预测因素(比值比 3.092,95%置信区间 1.744-5.484),而包膜侵犯不是(比值比 1.212,95%置信区间 0.890-1.651)。此外,多因素分析显示,男性、肿瘤直径>5mm 和年龄<45 岁是中央区淋巴结转移的独立预测因素(比值比 2.072、2.356、2.302;95%置信区间 1.483-2.894、1.792-3.099、1.748-3.031)。

结论

本研究支持甲状腺微小乳头状癌包膜侵犯和肿瘤局限于甲状腺时适合归为 T1 期,即甲状腺微小乳头状癌包膜侵犯可能不属于 TNM 分期 T3 中包含的最小甲状腺外侵犯。此外,甲状腺微小乳头状癌患者如果存在甲状腺外侵犯的危险因素、男性、年龄<45 岁或肿瘤直径>5mm,应考虑更积极的手术治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验